Risk factors for nosocomial infections caused by Gram-negative bacilli

Journal of Hospital Infection

Volumn 34, Issue 1, 1996, Pages 11-22

  Vatopoulos, A C ^a   Kalapothaki, V ^a   Legakis, N J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antibiotic resistance; Hospital infection; Risk factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; IMIPENEM; MONOBACTAM DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ARTICLE; CITROBACTER; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; GREECE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PROTEUS; PROVIDENCIA; PSEUDOMONAS; SERRATIA;

EID: 0029765615     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(96)90121-8     Document Type: Article

References (30)

1. Platt R, Goldmann DA, Hopkins CC. Epidemiology of nosocomial infections. In: Gorbach, Bartlet Blacklow (Eds), Infectious Diseases. Philadelphia: W. B. Saunders Co. 1992; 96-106.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91(Suppl. 3B); 72S-75S.
3. Legakis NJ, Tsakris A. Antibiotic resistance mechanisms in Gram-negative bacteria. The Greek experience. Int J Exper Clin Chemother 1992; 5: 83-91.
4. Legakis NJ, Tzouvelekis LS, Tsakris A, Legakis JB, Vatopoulos AC. On the incidence of antibiotic resistance among aerobic Gram-negative rods isolated in Greek hospitals. J Hosp Infect 1993; 24: 233-237.
5. Wenzel RP, Osterman CA, Donowitz LG et al. Identification of procedure-related nosocomial infections in high-risk patients. Rev Infect Dis 1981; 3: 701-706.
6. Rhame FS. Surveillance objectives: description epidemiology. Infect Control 1987; 8: 454-458.
7. Wenzel RP, Streed SA. Surveillance and the use of computers in hospital infection control. J Hosp Infect 1989; 13: 217-229.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16 128-140.
9. Lenette EH, Balows A, Hausler WJ, Shadomy HJ (Eds). Manual of Clinical Microbiology, Washington, DC: American Society for Microbiology, 1985.
10. Wenzel RP. Towards a global perspective of nosocomial infections. Eur J Clin Microbiol 1987; 6: 341-343.
11. Poulsen KB, Bremmelgaard A, Sorensen AI, Raahave D, Petersen JV. Estimated costs of postoperative wound infections. A case control study of marginal hospital and social security costs. Epidemiol Infect 1994; 113: 283-295.
12. Emory TG, Gaynes RP. An overview of the nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-442.
13. Gould IM. Risk factors for acquisition of multiply drug resistant Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13(Suppl. 1): 30-38.
14. Gross PA, De Mauro PJ, Van Antwerpen C, Wallenstein S, Chiang. Number of comorbidities as a predictor of nosocomial infection acquisition. Infect Control Hosp Epidemiol 1988; 9: 497-500.
15. Horn SD, Chachich B, Clopton C. Measuring severity of illness: a reliability study. Med Care 1983; 21: 705-714.
16. Gross PA, Beyt BE Jr, Decker MD et al. Description of case-mix adjusters by the Severity of Illness Working Group of the Society of Hospital Epidemiologists of America (SHEA) (Review). Infect Control Hosp Epidemiol 1988; 9: 309-316.
17. Tess BH, Glenister HM, Rodrigues LC, Wagner MB. Incidence of hospital-acquired infections and length of hsopital stay. Eur J Clin Microbiol Infect Dis 1993; 12: 81-86.
18. Freeman J, McGowan JE Jr. Day-specific incidence of nosocomial infection estimated from a prevalence survey. Am J Epidemiol 1981; 114: 888-901.
19. Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991; 91(Suppl. 3B): 179S-184S.
20. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis and prevention. Am J Med 1991; 91(Suppl. 3B): 65S-71S.
21. Goldmann DA, Pier GB. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev 1993; 6: 176-192.
22. Dickinson GM, Bisno AL. Infections associated with indwelling devices: infections related with extravascular devices. Antimicrob Agents Chemother 1989; 33: 602-607.
23. Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistant Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 1985; 27: 619-624.
24. Sanders CC, Sanders WE. Beta-lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15: 824-839.
25. Richard P, Delange ME, Merrien D, Barille S, Reynaud A, Minozzi C, Richet H. Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clin Infect Dis 1994; 19: 54-59.
26. de Champs C, Sauvant MP, Chanal C, Sirot D, Gazuy N, Malhuret R, Baguet JC, Sirot J. Prospective survey of colonization and infection caused by extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989; 27: 2887-2890.
27. Vatopoulos A, Phillipon A, Tsouvelekis L, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 635-648.
28. Vatopoulos AC, Tzouvelekis LS, Tzelepi E, Legakis NJ. Cross resistance to norfloxacin and other antimicrobial agents among clinical isolates of Gram-negative bacteria. Int J Exper Clin Chemother 1990; 3: 201-205.
29. Vatopoulos AC, Tsakris A, Tzouvelekis LS et al. Diversity of aminoglycoside resistance in Enterobacter cloacae in Greece. Europ J Clin Microbiol Infect Dis 1992; 11: 131-138.
30. Tsakris A, Vatopoulos AC, Johnson AP, Pitt TL, Legakis NJ, Tzouvelekis LS. Prevalence of a plasmid-mediated type II dihydrofolate reductase gene among trimethoprim-resistant urinary pathogens in Greek hospitals. J Antimicrob Chemother 1992; 29: 405-413.